Will we "see" you in New York at Moody's Capital 2026 Disruptive Growth and Life Sciences Conference September 9-10

Rhea-AI Summary

Fast Moving Consumer Goods (OTCID:GGII) announced that incubated client 20Slash20, a health and wellness company focused on eye health, will present at the Moody's Capital 2026 Disruptive Growth and Life Sciences Conference in New York on September 9-10, 2026.

Founder and CEO Dr. Roger Wu is scheduled to present at 9:35 AM in Room 2 on September 9, 2026, outlining 20Slash20's business platform, growth strategy, and its functional beverage The Eye Drink, designed for consumers who spend extended hours on digital devices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Dr. Roger Wu, CEO of 20Slash20 Inc, to Present The Eye Drink Company Overview at Moody's Capital 2026 Disruptive Growth and Life Sciences Conference September 9-10.

NEW YORK, NY / ACCESS Newswire / August 31, 2026 / As an incubated client of Fast Moving Consumer Goods (OTCID:GGII), 20Slash20, Inc., a health and wellness company focused on advancing eye health awareness through innovative consumer products and education, announced today that Dr. Roger Wu, Founder and CEO of 20Slash20, will present the company's vision, growth strategy, and market opportunities at the Moody's Capital 2026 Disruptive Growth and Life Sciences Conference September 9-10.

Dr. Wu's presentation is scheduled to begin at 9:35 AM in Room 2 on September 9, 2026, where he will provide investors, industry leaders, and strategic partners with an overview of 20Slash20's business platform, product innovation initiatives, and long-term growth objectives.

20Slash20 has gained recognition through its commitment to making eye health more accessible to consumers, including the development of The Eye Drink, a functional beverage designed specifically for people who spend extended hours daily on their cellphones, tablets, or computers to support their eye health and wellness. During the presentation, Dr. Wu will discuss emerging trends in preventive health, consumer wellness, and the expanding opportunities within the life sciences and functional nutrition sectors.

"We are excited to participate in Moody's Life Science Investment Meeting and share our vision with the investment community," said Dr. Roger Wu, Founder and CEO of 20Slash20. "The convergence of healthcare, preventive wellness, and consumer innovation presents significant opportunities for growth, and we look forward to discussing how 20Slash20 is positioned to create value in this evolving marketplace."

The Moody's Life Science Investment Meeting brings together investors, executives, entrepreneurs, and industry experts to explore emerging opportunities across the biotechnology, medical technology, healthcare, and life sciences sectors. The event serves as a platform for company presentations, investor engagement, networking, and discussions surrounding innovation and capital formation within the life sciences ecosystem.

About 20Slash20

20Slash20, Inc. is dedicated to advancing eye health awareness through innovative products, education, and preventive wellness initiatives. Led by Dr. Roger Wu, the company develops consumer-focused solutions designed to help individuals incorporate eye health support into their daily routines. Through science-driven innovation and strategic partnerships, 20Slash20, Inc. seeks to improve awareness and accessibility of eye health for consumers worldwide. To learn more about The Eye Drink or to book a personal meeting with Dr. Wu or to order the beverage, visit www.theeyedrink.com

About Moody's Capital 2026 Disruptive Growth and Life Sciences Conference September 9-10.

The Moody's Capital 2026 Disruptive Growth and Life Sciences Conference is a premier gathering of investors, entrepreneurs, healthcare executives, and industry thought leaders focused on emerging opportunities within the life sciences sector. The event provides a forum for innovative companies to present their business strategies, technologies, and growth plans while connecting with potential investors, strategic partners, and industry stakeholders. Attendees gain insight into market trends, investment activity, and advancements shaping the future of healthcare and life sciences. www.moodycapital.com/conference

About Fast Moving Consumer Goods

Fast Moving Consumer Goods is a nationwide ecosystem created to educate and support new founders, celebrities, CEOs, and doctors engaged in the formulation, manufacturing, launching, and scaling of their fast moving consumer goods brands. FMCG operates the nation's first fast moving consumer goods incubator and manages one of the largest communities of FMCG founders and CEOs with more than 45,000 LinkedIn members. www.fmcgstock.com

Media Contact

20Slash20, Inc.
Website: www.theeyedrink.com
Contact: Dr. Roger Wu
Email: info@theeyedrink.com

Fast Moving Consumer Goods
(619) 975-6556
Website: www.fmcgstock.com
LinkedIn Group: https://www.linkedin.com/groups/140132/

SOURCE: Fast Moving Consumer Goods, Inc.

View the original press release on ACCESS Newswire

FAQ

What is Fast Moving Consumer Goods (OTCID:GGII) announcing about 20Slash20 and The Eye Drink?

Fast Moving Consumer Goods announces its incubated client 20Slash20 will present The Eye Drink and company overview at Moody's Capital 2026 conference. According to Fast Moving Consumer Goods, the presentation will highlight 20Slash20's eye health-focused products, growth strategy, and market opportunities in preventive wellness and life sciences.

When and where will 20Slash20 present at Moody's Capital 2026 Disruptive Growth and Life Sciences Conference?

20Slash20 will present on September 9, 2026, at 9:35 AM in Room 2 in New York. According to 20Slash20, this session is part of the Moody's Capital 2026 Disruptive Growth and Life Sciences Conference held September 9-10, 2026.

What is The Eye Drink presented by 20Slash20 at Moody's Capital 2026 conference?

The Eye Drink is a functional beverage developed to support eye health and wellness for heavy digital-device users. According to 20Slash20, it targets people spending extended hours on cellphones, tablets, or computers, aligning with the company’s focus on preventive eye health and consumer wellness products.

How is Fast Moving Consumer Goods (GGII) connected to 20Slash20’s presentation at Moody's Capital 2026?

Fast Moving Consumer Goods, traded as OTCID:GGII, serves as an incubator for 20Slash20. According to Fast Moving Consumer Goods, 20Slash20 is an incubated client within its FMCG ecosystem, which supports founders in formulating, launching, and scaling fast moving consumer goods brands, including The Eye Drink.

What topics will Dr. Roger Wu cover in 20Slash20’s presentation at Moody's Capital 2026 conference?

Dr. Roger Wu will cover 20Slash20’s vision, business platform, product innovation, and long-term growth objectives. According to 20Slash20, he will also discuss trends in preventive health, consumer wellness, and opportunities in the life sciences and functional nutrition sectors for investors and partners.

What is Moody's Capital 2026 Disruptive Growth and Life Sciences Conference mentioned in relation to GGII and 20Slash20?

Moody's Capital 2026 Disruptive Growth and Life Sciences Conference is a New York event for investors and life sciences companies. According to Moody's Capital, it offers presentations, networking, and discussions on biotechnology, medical technology, healthcare, and life sciences innovation and capital formation.

How can investors or partners learn more or contact 20Slash20 about The Eye Drink after the 2026 conference?

Investors and partners can visit www.theeyedrink.com or email info@theeyedrink.com for more information. According to 20Slash20, the website supports learning about The Eye Drink, booking personal meetings with Dr. Roger Wu, and ordering the beverage directly.